FDA Approves Hyftor (sirolimus topical gel) for Facial Angiofibroma Associated with Tuberous Sclerosis

March 22, 2022 - The U.S. Food and Drug Administration has approved Hyftor (sirolimus topical gel) for the treatment of facial angiofibroma associated with tuberous sclerosis in adults and pediatric patients 6 years of age and...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news